[EN] SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROARYLE SUBSTITUÉS ET LEURS MÉTHODES D'UTILISATION
申请人:SUNSHINE LAKE PHARMA CO LTD
公开号:WO2017048675A1
公开(公告)日:2017-03-23
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
2‐ and 3‐Fluorocyclobutane Building Blocks for Organic and Medicinal Chemistry
作者:Andrii Malashchuk、Oleksandr P. Demchuk、Bohdan V. Razhyk、Vitalii O. Holumbievskyi、Oleksandr V. Kudryk、Anton V. Chernykh、Oleksandr V. Hryshchuk、Bohdan S. Sosunovych、Dmytro M. Volochnyuk、Bohdan V. Vashchenko、Oleksandr O. Grygorenko
DOI:10.1002/ejoc.202400493
日期:2024.8.26
Multigram synthesis of 2- and 3-monofluorinated cyclobutane building blocks was disclosed. In both cases, fluorocyclobutanecarboxylic acids were the key intermediates used to obtain all other derivatives, e. g., amines, alcohols, bromides, thiols, sulfonyl chlorides, etc. For both target chemotypes, diastereopure cis- and trans-isomers of the corresponding carboxylic acids and amines were obtained